Intellia Therapeutics, Inc. (NTLA)

16.39 +1.08 (+7.05%) USD  |  NASDAQ  |  Apr 22, 15:42
More

Intellia Therapeutics Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Personalis, Inc. Upgrade
Novavax, Inc. Upgrade